glp-1 and gip/glp-1 receptor agonists Schematic illustration of monoagonists, dual triple Bridging the gap between GLP1-receptor
Description
A new blockbuster class of therapeutics, glucagon-like peptide 1 (GLP-1) analogs (eg, semaglutide), shows promise at curbing both diseases

Microdose GLP-1 chart, Noom protocol, autoimmune benefits, safety risks, doctor-approved titration for Ozempic/Wegovy/Zepbound.

95% CI 0.97, 1.15)

Patients should not automatically stop their long-acting insulin when starting a GLP-1 receptor agonist, but the insulin dose should be reduced by 20% initia...

Obesity in India: A Growing Concern From fast food joints to office chairs, have you noticed how obesity is taking over
